• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation.全内镜下肿瘤长度作为预测食管鳞癌新辅助治疗反应的标志物值得进一步研究。
J Thorac Dis. 2018 Apr;10(Suppl 9):S1122-S1123. doi: 10.21037/jtd.2018.03.144.
2
ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.ERCC1表达和肿瘤退缩可预测接受三联综合治疗的食管鳞状细胞癌患者的生存情况。
Pathol Res Pract. 2014 Oct;210(10):656-61. doi: 10.1016/j.prp.2014.06.013. Epub 2014 Jun 27.
3
Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma.内镜超声检查对于监测食管鳞癌新辅助放化疗的肿瘤反应是有用的。
Am J Surg. 2012 Feb;203(2):191-7. doi: 10.1016/j.amjsurg.2011.01.027. Epub 2011 Jun 16.
4
IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma.新辅助治疗后IDO1表达升高预示食管鳞状细胞癌的病理反应不佳及预后不良。
Front Oncol. 2020 Jul 7;10:1099. doi: 10.3389/fonc.2020.01099. eCollection 2020.
5
The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study.肿瘤长度对可切除食管鳞状细胞癌的预后价值：一项回顾性研究。
PeerJ. 2017 Jan 31;5:e2943. doi: 10.7717/peerj.2943. eCollection 2017.
6
Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.食管癌扩散加权成像中b值的优化：测量大体肿瘤体积的纵向长度并评估放化疗疗效。
J Cancer Res Ther. 2017;13(5):748-755. doi: 10.4103/jcrt.JCRT_630_17.
7
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.新辅助化疗后行根治性食管切除术治疗的食管鳞状细胞癌中，CD44和CD133作为预后标志物的表达状态。
Oncol Rep. 2016 Dec;36(6):3333-3342. doi: 10.3892/or.2016.5133. Epub 2016 Sep 28.
8
The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.在对日本305家指定癌症护理医院的5016例患者进行的分析中，新辅助治疗在可切除的局部晚期胸段食管鳞状细胞癌中的应用。
Int J Clin Oncol. 2018 Feb;23(1):81-91. doi: 10.1007/s10147-017-1178-y. Epub 2017 Aug 9.
9
Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.（18）F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描中肿瘤/正常食管比值在食管鳞状细胞癌新辅助化疗后的疗效及预后分层中的应用
J Gastroenterol. 2016 Aug;51(8):788-95. doi: 10.1007/s00535-015-1150-4. Epub 2015 Dec 15.
10
A Pathological Study of Residual Cancer in the Esophageal Wall Following Neoadjuvant Chemoradiotherapy: Focus on Esophageal Squamous Cell Carcinoma Patients with False Negative Preoperative Endoscopic Biopsies.新辅助放化疗后食管壁残留癌的病理学研究：聚焦术前内镜活检假阴性的食管鳞状细胞癌患者
Ann Surg Oncol. 2015 Oct;22(11):3647-52. doi: 10.1245/s10434-015-4412-8. Epub 2015 Feb 12.

本文引用的文献

1
Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.诊断时初始全内镜肿瘤长度在接受食管切除术的可手术性食管鳞状细胞癌中的预后作用，无论是否接受新辅助同步放化疗。
J Thorac Dis. 2017 Sep;9(9):3193-3207. doi: 10.21037/jtd.2017.08.108.
2
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas.可切除食管/食管胃交界腺癌和鳞状细胞癌患者新辅助治疗方案的最新进展
Curr Oncol Rep. 2017 Jan;19(1):7. doi: 10.1007/s11912-017-0559-8.
3
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.可切除食管癌新辅助化疗或放化疗后的生存：更新的荟萃分析。
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
4
Update on the paris classification of superficial neoplastic lesions in the digestive tract.消化道浅表性肿瘤性病变的巴黎分类更新
Endoscopy. 2005 Jun;37(6):570-8. doi: 10.1055/s-2005-861352.

Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation.

作者信息

Deng Yu-Feng, Yuan Tian-Zhu

机构信息

Department of Thoracic Surgery, Liuzhou Worker's Hospital/Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou 545005, China.

出版信息

J Thorac Dis. 2018 Apr;10(Suppl 9):S1122-S1123. doi: 10.21037/jtd.2018.03.144.

DOI:10.21037/jtd.2018.03.144
PMID:29850193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5949427/
Abstract
摘要